Stefan Longobardi, Shoon Lei Oo, Asis Shrestha, anup kumar Trikannad, Sruthi Vellanki, Hira Imad Cheema, Sanjay Muttineni, Syed Naqvi, Anushareddy Muddasani, Sasya Dronavalli, Samer Al Hadidi, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, Niels Weinhold, Carolina D. Schinke. "Influence of genomic and clinical high-risk features on outcomes after BCMA-directed bispecific antibody therapy in relapsed/refractory multiple myeloma.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.7534